269 related articles for article (PubMed ID: 35745675)
1. Tetanus Toxin Fragment C: Structure, Drug Discovery Research and Production.
Bayart C; Mularoni A; Hemmani N; Kerachni S; Jose J; Gouet P; Paladino J; Le Borgne M
Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745675
[TBL] [Abstract][Full Text] [Related]
2. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
Abreu PA; Miyasato PA; Vilar MM; Dias WO; Ho PL; Tendler M; Nascimento AL
Infect Immun; 2004 Oct; 72(10):5931-7. PubMed ID: 15385496
[TBL] [Abstract][Full Text] [Related]
3. The combined use of analytical tools for exploring tetanus toxin and tetanus toxoid structures.
Bayart C; Peronin S; Jean E; Paladino J; Talaga P; Borgne ML
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1054():80-92. PubMed ID: 28448854
[TBL] [Abstract][Full Text] [Related]
4. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
[TBL] [Abstract][Full Text] [Related]
5. Single immunization of non-adjuvanted recombinant TTFC-mi3 nanoparticle vaccine elicited a rapid and potent protective immunity against tetanus.
He Q; Chen Y; Li Y; Cheng X; Li X; Wu M; Wan J; Luo P; Wang Y; Gu J; Zhang Y
Vaccine; 2024 May; ():. PubMed ID: 38824085
[TBL] [Abstract][Full Text] [Related]
6. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
[TBL] [Abstract][Full Text] [Related]
7. The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity.
Yu R; Xu J; Hu T; Chen W
Mediators Inflamm; 2020; 2020():9596129. PubMed ID: 32714092
[TBL] [Abstract][Full Text] [Related]
8. Lactococcus lactis: high-level expression of tetanus toxin fragment C and protection against lethal challenge.
Wells JM; Wilson PW; Norton PM; Gasson MJ; Le Page RW
Mol Microbiol; 1993 Jun; 8(6):1155-62. PubMed ID: 8361360
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis.
Norton PM; Brown HW; Wells JM; Macpherson AM; Wilson PW; Le Page RW
FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):167-77. PubMed ID: 8809553
[TBL] [Abstract][Full Text] [Related]
10. Tetanus toxin fragment C fused to flagellin makes a potent mucosal vaccine.
Lee SE; Nguyen CT; Kim SY; Thi TN; Rhee JH
Clin Exp Vaccine Res; 2015 Jan; 4(1):59-67. PubMed ID: 25649002
[TBL] [Abstract][Full Text] [Related]
11. Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7.
Oosterhuis K; Ohlschläger P; van den Berg JH; Toebes M; Gomez R; Schumacher TN; Haanen JB
Int J Cancer; 2011 Jul; 129(2):397-406. PubMed ID: 21207427
[TBL] [Abstract][Full Text] [Related]
12. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C.
Norton PM; Wells JM; Brown HW; Macpherson AM; Le Page RW
Vaccine; 1997; 15(6-7):616-9. PubMed ID: 9178460
[TBL] [Abstract][Full Text] [Related]
13. Induction of protection against tetanus toxin in mice by tetanus toxoid-liposome conjugate.
Naito S; Horino A; Komiya T; Fukuda T; Takahashi M; Ami Y; Suzaki Y; Oka T; Okuma K; Morokuma M; Nakano Y; Mori M; Nishinohara S; Komuro K; Uchida T
Int Arch Allergy Immunol; 1998 Jul; 116(3):215-9. PubMed ID: 9693269
[TBL] [Abstract][Full Text] [Related]
14. Expression and delivery of tetanus toxin fragment C fused to the N-terminal domain of SipB enhances specific immune responses in mice.
Jang JI; Kim JS; Eom JS; Kim HG; Kim BH; Lim S; Bang IS; Park YK
Microbiol Immunol; 2012 Sep; 56(9):595-604. PubMed ID: 22708880
[TBL] [Abstract][Full Text] [Related]
15. Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis.
Reveneau N; Alonso S; Jacob-Dubuisson F; Mercenier A; Locht C
Vaccine; 2001 Dec; 20(5-6):926-33. PubMed ID: 11738759
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations.
Reveneau N; Geoffroy MC; Locht C; Chagnaud P; Mercenier A
Vaccine; 2002 Mar; 20(13-14):1769-77. PubMed ID: 11906764
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical and immunochemical assays for monitoring consistent production of tetanus toxoid.
Metz B; Tilstra W; van der Put R; Spruit N; van den Ijssel J; Robert J; Hendriksen C; Kersten G
Biologicals; 2013 Jul; 41(4):231-7. PubMed ID: 23726755
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the detoxification mechanism of formaldehyde-treated tetanus toxin.
Thaysen-Andersen M; Jørgensen SB; Wilhelmsen ES; Petersen JW; Højrup P
Vaccine; 2007 Mar; 25(12):2213-27. PubMed ID: 17240009
[TBL] [Abstract][Full Text] [Related]
19. Transcutaneous delivery of tetanus toxin Hc fragment induces superior tetanus toxin neutralizing antibody response compared to tetanus toxoid.
Johnston L; Mawas F; Tierney R; Qazi O; Fairweather N; Sesardic D
Hum Vaccin; 2009 Apr; 5(4):230-6. PubMed ID: 18948742
[TBL] [Abstract][Full Text] [Related]
20. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.
Grangette C; Müller-Alouf H; Geoffroy M; Goudercourt D; Turneer M; Mercenier A
Vaccine; 2002 Sep; 20(27-28):3304-9. PubMed ID: 12213400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
